These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pharmacology of the adrenergic blocking agent dimethylpiperidino ethyl guanidine (author's transl)]. Chen WZ; Wang ZM; Ting KS Yao Xue Xue Bao; 1979 Aug; 14(8):480-5. PubMed ID: 532648 [No Abstract] [Full Text] [Related]
5. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission. Kadzielawa K; Gumulka W Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771 [No Abstract] [Full Text] [Related]
6. Pharmacological studies on guanethidine derivatives. IV. Adrenergic neurone blocking action of 2,3,4,5-tetrahydro-1H-2-benz-azepine-2-carboxamidine sulfate. Ozawa H; Otsuki I Chem Pharm Bull (Tokyo); 1967 Dec; 15(12):1875-82. PubMed ID: 5590688 [No Abstract] [Full Text] [Related]
7. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent. Bapat SK; Dhawan BN; Srimal RC Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115 [No Abstract] [Full Text] [Related]
8. On the peripheral pharmacology of amitriptyline. Cairncross KD Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):438-48. PubMed ID: 5891351 [No Abstract] [Full Text] [Related]
9. Sympathetic nervous system blocking agents. 3. Derivatives of benzylguanidine. Short JH; Darby TD J Med Chem; 1967 Sep; 10(5):833-40. PubMed ID: 6057834 [No Abstract] [Full Text] [Related]
10. ADRENERGIC NEURONE BLOCKING ACTIVITY OF SOME ARALKYLGUANIDINES. FIELDEN R; GREEN AL; WILEY GL Br J Pharmacol Chemother; 1965 Apr; 24(2):395-407. PubMed ID: 14320854 [No Abstract] [Full Text] [Related]
11. Role of adrenergic neurone blockade in the hypotensive action of propranolol. Eliash S; Weinstock M Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571 [TBL] [Abstract][Full Text] [Related]
12. THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS. FIELDEN R; ROE AM; WILLEY GL Br J Pharmacol Chemother; 1964 Dec; 23(3):486-507. PubMed ID: 14256809 [TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacology of alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyl-dopa) and alpha-methyl-norepinephrine. I. Kadzielawa K Int J Neuropharmacol; 1967 Nov; 6(6):435-52. PubMed ID: 4296969 [No Abstract] [Full Text] [Related]
14. Sympathetic nervous system blocking agents. IV. Synthesis of 2-(2-methylthioethylamino)ethylguanidine sulfate and related compounds. Short JH; Darby TD J Med Chem; 1968 Jul; 11(4):848-54. PubMed ID: 5671253 [No Abstract] [Full Text] [Related]
15. Adrenergic neurone blocking agents: tolerance and hypersensitivity to adrenaline and noradrenaline. Green AF; Robson RD Br J Pharmacol Chemother; 1965 Oct; 25(2):497-506. PubMed ID: 5866728 [No Abstract] [Full Text] [Related]
16. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives. Abbs ET; Dodd MG Br J Pharmacol; 1974 Jun; 51(2):237-47. PubMed ID: 4451743 [TBL] [Abstract][Full Text] [Related]
17. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs. Farmer JB; Rand MJ; Wilson J Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550 [No Abstract] [Full Text] [Related]
18. Adrenotropic receptors in skeletal muscle. Bowman WC; Raper C Ann N Y Acad Sci; 1967 Feb; 139(3):741-53. PubMed ID: 5232338 [No Abstract] [Full Text] [Related]
19. Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockade. Fielden R; Green AL Br J Pharmacol Chemother; 1968 Feb; 32(2):350-9. PubMed ID: 5646312 [No Abstract] [Full Text] [Related]
20. Sympathetic nervous system blocking agents. V. Derivatives of isobutyl-, t-butyl-, and neopentylguanidine. Short JH; Ours CW; Ranus WJ J Med Chem; 1968 Nov; 11(6):1129-35. PubMed ID: 5680024 [No Abstract] [Full Text] [Related] [Next] [New Search]